Diagnexia and Stratipath: Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling tool, to healthcare providers...

Techcyte: Autonomous slide quality control and mitosis counting to be integrated into the Techcyte Fusion™ platform. Orem, UT, and Nijmegen, Netherlands — March 20, 2025 — Techcyte, a leader in AI-powered digital...

March 6, 2025 at 09:30 a.m. EET. The regional health authority of Sardinia in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics. This collaboration involves utilizing Aiforia's clinical AI solutions to analyze...

Indica Labs: Learn about the latest advancements in AI-powered pathology CRC Macrodissect AI and Breast HER2 AI Sneak Peek Date: 27 March 2025 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 15:00 – 16:00...

Aiforia obtained the In Vitro Diagnostic Regulation (IVDR) certification and successfully launches three new CE-IVD marked AI solutions for breast and prostate cancer diagnostics Aiforia Technologies Plc, Press Release, February 20, 2025 at...

Aiforia selected to provide AI-assisted diagnostic solutions to regional health authorities in Italy Aiforia Technologies Plc PRESS RELEASE January 24, 2025 at 3.45 p.m. EET The Lombardy region health authorities in Italy have selected...